| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-5,794 | -4,154 | -4,965 | -2,831 | -2,884 | -2,647 | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
4 | 6 | - | - | - | - | |
Depreciation | ||||||
- | - | 5 | 7 | 9 | 9 | |
Stock-based compensation | ||||||
1,755 | 889 | 800 | 508 | 220 | 24 | |
Noncash interest expense | ||||||
10 | - | - | - | - | - | |
Change in fair value of derivative liabilities | ||||||
102 | - | - | - | - | - | |
Warrant modification expense | ||||||
412 | - | - | - | - | - | |
Loss on extinguishment of derivative liability | ||||||
-288 | - | - | - | - | - | |
Discount amortization of promissory notes | ||||||
- | - | 1,197 | 0 | 384 | - | |
Benefit component of Promissory Notes | ||||||
- | - | - | - | - | -885 | |
Revaluation of warrants to purchase Common stock | ||||||
- | - | 549 | 383 | 962 | 138 | |
Changes in operating assets and liabilities: | ||||||
Trade receivable | ||||||
16 | 71 | - | 1 | -16 | 8 | |
Trade receivable | ||||||
- | - | 18 | - | - | - | |
Other accounts receivable and prepaid expenses | ||||||
173 | 34 | 14 | -44 | 67 | -33 | |
Inventory | ||||||
-23 | 68 | 9 | -4 | 36 | -31 | |
Other assets | ||||||
- | 4 | - | - | - | - | |
Increase in trade payables | ||||||
- | - | - | 24 | -43 | - | |
Trade payables | ||||||
-64 | 25 | 86 | - | - | 83 | |
Other accounts payable and accrued expenses | ||||||
-167 | -182 | - | - | - | - | |
Accrued severance pay, net | ||||||
-50 | 43 | - | - | - | - | |
Other accounts payable | ||||||
- | - | 183 | 244 | -105 | 183 | |
Accrued severance pay, net | ||||||
- | - | 4 | - | - | - | |
Increase in accrued severance pay, net | ||||||
- | - | - | 90 | -1 | -2 | |
Increase in long-term prepaid expense | ||||||
- | - | - | 5 | - | - | |
Net cash used in investment activities | ||||||
- | - | - | - | -1 | -4 | |
Net cash used in operating activities | ||||||
-3,874 | -3,550 | -2,182 | -1,533 | - | - | |
Cash flows from investing activities: | ||||||
Increase in long term prepaid expense | ||||||
- | - | - | - | 0 | - | |
Accrued interest on Promissory Notes | ||||||
- | - | - | - | 65 | 372 | |
Net cash used in operating activities | ||||||
- | - | - | - | -1,480 | -900 | |
Purchases of property plant and equipment | ||||||
- | 8 | - | 8 | 1 | 4 | |
Net cash used in investing activities | ||||||
- | -8 | - | -8 | - | - | |
Cash flows from financing activities: | ||||||
Proceeds from issuance of Common stock, Preferred D stock and warrants, net of issuance costs | ||||||
- | - | 5,056 | 0 | - | - | |
Net proceeds from exercise of warrants | ||||||
- | 91 | - | - | - | - | |
Proceeds from issuance of convertible notes and warrants | ||||||
475 | - | - | - | - | - | |
Payments of convertible notes | ||||||
475 | - | - | - | - | - | |
Proceeds from issuance of Convertible Promissory Note and warrants | ||||||
- | - | 1,380 | 0 | 3,005 | 0 | |
Proceeds from sale of common stock | ||||||
630 | - | - | - | - | - | |
Proceeds from issuance of Series E Preferred Stock | ||||||
3,620 | - | - | - | - | - | |
Proceeds from exercise of options | ||||||
66 | 3 | - | - | - | - | |
Proceeds from exercise of options | ||||||
- | - | - | 33 | 0 | 900 | |
Net cash provided by financing activities | ||||||
- | - | - | - | 3,005 | 900 | |
Net cash provided by financing activities | ||||||
4,316 | 94 | 6,436 | 33 | - | - | |
Net increase in cash and cash equivalents | ||||||
442 | -3,464 | - | - | - | - | |
Increase (decrease) in cash and cash equivalents | ||||||
- | - | 4,254 | -1,508 | 1,524 | -4 | |
Supplemental non-cash financing and investing activities: | ||||||
Cash paid for interest | ||||||
5 | - | - | - | - | - | |
Reclass warrants to non-derivative instruments | ||||||
196 | - | - | - | - | - | |
Exchange of common Stock into Preferred Stock | ||||||
275 | 250 | - | - | - | - | |
Discount on convertible notes | ||||||
414 | - | - | - | - | - | |
Stock-based compensation- ASU 2016-09 adoption | ||||||
- | - | - | - | 0 | - | |
Carve out of warrants' fair value from Convertible Promissory Notes | ||||||
- | - | 852 | 0 | - | - | |
Conversion of convertible notes and accrued interest into Common and Preferred D stock | ||||||
- | - | 1,762 | 0 | - | - | |
Cashless exercise of warrants | ||||||
- | - | 2,628 | 0 | - | - | |
Stock-based compensation - ASU 2016-09 adoption | ||||||
- | - | - | 11 | - | - | |
Issuance costs | ||||||
- | - | - | - | - | 86 | |
Conversion of Promissory Notes into Preferred B-1, B-2 stock and Preferred C stock | ||||||
- | - | - | - | 5,066 | 0 | |